KYNB
Kyntra Bio·NASDAQ
--
--(--)
--
--(--)
4.79 / 10
Netural
The fund-flow assessment is positive at 7.3/10, highlighting robust capital inflow despite a negative block-trend. Analyst coverage is limited to one institution with a Strong Buy rating, but the historical win rate is only 50%, tempering conviction. Together, strong money flow and a supportive analyst headline contrast with neutral technicals and fundamentals, creating a balanced yet cautious investment picture.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-24
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate50.0%
Is money flowing into or out of KYNB?
- KYNB holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.79/10 (Netural).
